ZACKS·2026-02-02 15:40Group 1 - Alkermes (ALKS) is currently performing well in the Medical sector, with a year-to-date gain of approximately 21.1%, significantly outperforming the average gain of 6.3% for Medical stocks [4] - The Zacks Rank for Alkermes is 1 (Strong Buy), indicating strong analyst sentiment and a positive earnings outlook, with a 9% increase in the consensus estimate for full-year earnings over the past 90 days [3] - Alkermes belongs to the Medical - Biomedical and Genetics industry, which includes 450 stocks and is currently ranked 94 in the Zacks Industry Rank, with an average gain of 20.5% year-to-date [5] Group 2 - CASI Pharmaceuticals Inc. is another Medical stock that has outperformed the sector, with a year-to-date return of 20% and a Zacks Rank of 2 (Buy) [4][5] - The Medical - Drugs industry, to which CASI Pharmaceuticals belongs, is ranked 154 and has seen a modest gain of 2.1% this year [6] - Investors in the Medical sector should monitor both Alkermes and CASI Pharmaceuticals for their strong performance trends [6]